PPBP [4-phenyl-1-(4-phenylbutyl) piperidine] decreases brain injury after transient focal ischemia in rats

Stroke

Volumn 27, Issue 11, 1996, Pages 2120-2123

  Takahashi, Hiroshi ^a   Kirsch, Jeffrey R ^a,c   Hashimoto, Kenji ^b   London, Edythe D ^b   Koehler, Raymond C ^a   Traystman, Richard J ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c Dept Anesth and Critical Care Med ^*  (United States)

Author keywords

cerebral ischemia, focal; neuronal damage; rats; receptors, sigma

Indexed keywords

4 PHENYL 1 (4 PHENYLBUTYL)PIPERIDINE; PIPERIDINE DERIVATIVE; SIGMA OPIATE RECEPTOR; SODIUM CHLORIDE; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION; BRAIN INJURY; BRAIN SIZE; CONTROLLED STUDY; CORPUS STRIATUM; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSIENT ISCHEMIC ATTACK;

EID: 0029847364     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.11.2120     Document Type: Article

References (22)

1. Lesage AS, De Loore KL, Peeters L, Leysen JE. Neuroprotective sigma ligands interfere with the glutamate-activated NOS pathway in hippocampal cell culture. Synapse. 1995;20:156-164.
2. Lockhart BP, Soulard P, Benicourt C, Privat A. Junien J-L. Distinct neuroprotective profiles for σ ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies. Brain Res. 1995;675:110-120.
3. 3H]ifenprodil binding to σ receptors in rat brain. Eur J Pharmacol. 1993;236:159-163.
4. Takahashi H, Kirsch JR, Hashimoto K, London ED, Koehler RC, Traystman RJ. PPBP [4-phenyl-1-(4-phenylbutyl) piperidine, a potent σ-receptor ligand, decreases brain injury following transient focal ischemia in cats. Stroke. 1995;26:1676-1682.
5. Dietrich WD. Editorial comment on 'PPBP [4-phenyl-1-(4-phenylbutyl) piperidine, a potent σ-receptor ligand, decreases brain injury following transient focal ischemia in cats.' Stroke. 1995;26:1682.
6. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989; 20:84-91.
7. Koizumi J, Yoshida Y. Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema, I: a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke. 1986;8:1-8.
8. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurological examination. Stroke. 1986; 17:472-476.
9. Su T-P. Delineating biochemical and functional properties of sigma receptors: emerging concepts. Crit Rev Neurobiol. 1993;7:187-203.
10. Lodge D, Johnson KM. Noncompetitive excitatory amino acid receptor antagonists. Trends Neurosci. 1990;11:81-86.
11. Lysko PG, Feuerstein G. Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor: protection by SKF 10,047. Neurosci Lett. 1990;120:217-220.
12. Carter C, Benavides J, Legendre P, Vincent JD, Noel F, Thuret F, Lloyd KG, Arbilla S, Zivkovic B, MacKenzie ET. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II: evidence for N-methyl-D-aspartate receptor antagonist properties. J Pharinacol Exp Ther. 1988;247:1222-1232.
13. Gotti B, Duverger D, Bertin J, Carter C, Dupont R, Frost J, Gaudilliere B, MacKenzie ET, Rousseau J, Scatton B, Wick A. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents, I: evidence for efficacy in models of focal cerebral ischemia. J Pharmacol Exp Ther. 1988;247:1211-1221.
14. Baskaya MK, Rao AM, Donaldson D, Prasad MR, Dempsey RJ. Effect of ifenoprodil on infarct size, blood brain barrier breakdown, and edema formation after focal cerebral ischemia in the cat. Soc Neurosci Abstr. 1995;21:995. Abstract.
15. Lysko PG, Yue T-L, Gu J-L, Feuerstein G. Neuroprotective mechanism of (+)SKF 10,047 in vitro and in gerbil global brain ischemia. Stroke. 1992;23:1319-1324.
16. Lysko PG, Gagnon RC, Yue T-L, Gu J-L, Feuerstein G. Neuroprotective effects of SKF 10,047 in cultured rat cerebellar neurons and in gerbii global brain ischemia. Stroke. 1992;23:414-419.
17. Willette RN, Lysko PG, Sauermelch CF. A comparison of (+)SK&F 10047 and MK-801 on cortical spreading depression, Brain Res. 1994;648:347-351.
18. Contreras PC, Raga DM, Bremer ME, Lanthom TH, Gray NM, Iyengar S, Jacobson AE, Rice KC, de Costa BR. Evaluation of U-50,488H analogs for neuroprotective activity in the gerbil. Brain Res. 1991;546:79-82.
19. Walker JM, Bowen WD, Walker FO, Matsumoto RR, de Costa B, Rice KC. Sigma receptors: biology and function. Pharmacol Rev. 1990;42:355-402.
20. Wu X-Z, Bell JA, Spivak CE, London ED, Su T-P. Electrophysiological and binding studies on intact NCB-20 cells suggest presence of a low affinity sigma receptor. J Pharmacol Exp Ther. 1991; 257:351-359.
21. Lobner D, Lipton P. σ-Ligands and non-competitive NMDA antagonists inhibit glutamate release during cerebral ischemia. Neurosci Lett. 1990;117:169-174.
22. Sharp FR, Butmun M, Koistinaho J, Aardalen K, Nakki R, Massa SM, Swanson RA, Sagar SM. Phencyclidine induction of the hsp 70 stress gene in injured pyramidal neurons is mediated via multiple receptors and voltage gated calcium channels, Neuroscience. 1994; 62:1079-1092.